Bright Minds Biosciences Stock Today

DRUG Stock  USD 0.97  0.12  11.01%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 23

 
High
 
Low
Low
Bright Minds is trading at 0.97 as of the 1st of May 2024. This is a -11.01% down since the beginning of the trading day. The stock's lowest day price was 0.93. Bright Minds has about a 23 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Bright Minds Biosciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 2nd of March 2024 and ending today, the 1st of May 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
22nd of March 2021
Category
Healthcare
Classification
Health Care
Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT medicines to improve the lives of patients with severe and life-altering diseases. The company was incorporated in 2019 and is headquartered in Vancouver, Canada. Bright Minds is traded on NASDAQ Exchange in the United States.. The company has 4.46 M outstanding shares of which 75.7 K shares are currently shorted by private and institutional investors with about 3.12 trading days to cover. More on Bright Minds Biosciences

Moving together with Bright Stock

  0.78DVAX Dynavax Technologies Financial Report 7th of May 2024 PairCorr
  0.66EGRX Eagle PharmaceuticalsPairCorr

Moving against Bright Stock

  0.89HCM HUTCHMED DRCPairCorr
  0.7FLGC Flora Growth Corp Buyout TrendPairCorr
  0.67CGC Canopy Growth Corp TrendingPairCorr
  0.65ACB Aurora Cannabis TrendingPairCorr
  0.53BHC Bausch Health Companies Financial Report 2nd of May 2024 PairCorr

Bright Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Bright Minds' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Bright Minds or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Thematic IdeaPharmaceutical Products (View all Themes)
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Pharmaceutical Products, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors)
Financial Strength
Based on the key indicators related to Bright Minds' liquidity, profitability, solvency, and operating efficiency, Bright Minds Biosciences is not in a good financial situation at this time. It has a very high odds of going through financial crisis in June. Financial strength of Bright Minds Biosciences is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Total Current Liabilities567.5 K323 K
Way Up
Slightly volatile
Total Assets8.8 M7.9 M
Moderately Up
Slightly volatile
Total Current Assets8.7 M7.8 M
Moderately Up
Slightly volatile
Bright Minds' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Bright Minds' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Bright Minds' financial leverage. It provides some insight into what part of Bright Minds' total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Bright Minds' books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Bright Minds deploys its capital and how much of that capital is borrowed.
Liquidity
Bright Minds cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 73.55 K in liabilities. Bright Minds Biosciences has a current ratio of 22.42, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Bright Minds until it has trouble settling it off, either with new capital or with free cash flow. So, Bright Minds' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bright Minds Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bright to invest in growth at high rates of return. When we think about Bright Minds' use of debt, we should always consider it together with cash and equity.

Change In Working Capital

(805,170)
Bright Minds Biosciences (DRUG) is traded on NASDAQ Exchange in USA. It is located in 19 Vestry Street, New York, NY, United States, 10013 and employs 5 people. Bright Minds is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.84 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bright Minds's market, we take the total number of its shares issued and multiply it by Bright Minds's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bright Minds Biosciences conducts business under Biotechnology sector and is part of Health Care industry. The entity has 4.46 M outstanding shares of which 75.7 K shares are currently shorted by private and institutional investors with about 3.12 trading days to cover. Bright Minds Biosciences currently holds about 8.64 M in cash with (7.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.71.
Check Bright Minds Probability Of Bankruptcy
Ownership Allocation
Bright Minds Biosciences retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months.
Check Bright Ownership Details

Bright Stock Price Odds Analysis

In reference to a normal probability distribution, the odds of Bright Minds jumping above the current price in 90 days from now is under 95%. The Bright Minds Biosciences probability density function shows the probability of Bright Minds stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Bright Minds Biosciences has a beta of -1.1065 suggesting Additionally, bright Minds Biosciences has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
  Odds Below 0.97HorizonTargetOdds Above 0.97
5.34%90 days
 0.97 
94.64%
Based on a normal probability distribution, the odds of Bright Minds to move above the current price in 90 days from now is under 95 (This Bright Minds Biosciences probability density function shows the probability of Bright Stock to fall within a particular range of prices over 90 days) .

Bright Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Bright Minds that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Bright Minds' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Bright Minds' value.
InstituionRecorded OnShares
Advisorshares Investments, Llc2023-12-31
188.1 K
Hrt Financial Llc2023-12-31
16.8 K
Renaissance Technologies Corp2023-12-31
12 K
Virtu Financial Llc2023-12-31
10.4 K
Ubs Group Ag2023-12-31
622
Royal Bank Of Canada2023-12-31
278
Aspire Private Capital, Llc2024-03-31
100.0
Blackrock Inc2023-12-31
1.0
View Bright Minds Diagnostics

Bright Minds Historical Income Statement

Bright Minds Biosciences Income Statement is one of the three primary financial statements used for reporting Bright's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Bright Minds Biosciences revenue and expense. Bright Minds Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Bright Minds' Reconciled Depreciation is most likely to increase significantly in the upcoming years. View More Fundamentals

Bright Stock Against Markets

Picking the right benchmark for Bright Minds stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Bright Minds stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Bright Minds is critical whether you are bullish or bearish towards Bright Minds Biosciences at a given time. Please also check how Bright Minds' historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Bright Minds without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Sectors Now

   

Sectors

List of equity sectors categorizing publicly traded companies based on their primary business activities
All  Next Launch Module

Bright Minds Corporate Management

Elected by the shareholders, the Bright Minds' board of directors comprises two types of representatives: Bright Minds inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bright. The board's role is to monitor Bright Minds' management team and ensure that shareholders' interests are well served. Bright Minds' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bright Minds' outside directors are responsible for providing unbiased perspectives on the board's policies.
FCCP MDChief OfficerProfile
Jan MScInterim DirectorProfile
Emer MBAConsultantProfile
Gideon ShapiroVP DiscoveryProfile
Ian McDonaldCEO, CoFounderProfile

How to buy Bright Stock?

Before investing in Bright Minds, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Bright Minds. To buy Bright Minds stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Bright Minds. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Bright Minds stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Bright Minds Biosciences stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Bright Minds Biosciences stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Bright Minds Biosciences, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Bright Stock please use our How to Invest in Bright Minds guide.

Already Invested in Bright Minds Biosciences?

The danger of trading Bright Minds Biosciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Bright Minds is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Bright Minds. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Bright Minds Biosciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Bright Minds Biosciences is a strong investment it is important to analyze Bright Minds' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bright Minds' future performance. For an informed investment choice regarding Bright Stock, refer to the following important reports:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Bright Minds Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Complementary Tools for Bright Stock analysis

When running Bright Minds' price analysis, check to measure Bright Minds' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bright Minds is operating at the current time. Most of Bright Minds' value examination focuses on studying past and present price action to predict the probability of Bright Minds' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bright Minds' price. Additionally, you may evaluate how the addition of Bright Minds to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Money Managers
Screen money managers from public funds and ETFs managed around the world
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Is Bright Minds' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bright Minds. If investors know Bright will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bright Minds listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.29)
Return On Assets
(0.45)
Return On Equity
(0.79)
The market value of Bright Minds Biosciences is measured differently than its book value, which is the value of Bright that is recorded on the company's balance sheet. Investors also form their own opinion of Bright Minds' value that differs from its market value or its book value, called intrinsic value, which is Bright Minds' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bright Minds' market value can be influenced by many factors that don't directly affect Bright Minds' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bright Minds' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bright Minds is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bright Minds' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.